J. Kreuter

发表

Cationic lipid-protamine-DNA (LPD) complexes for delivery of antisense c-myc oligonucleotides.

A. Zimmer, M. Junghans, S. Loitsch, 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Physicochemical characterization of polyacrylic nanoparticles

J. Kreuter, 1983 .

Comparison of scanning electron microscopy, dynamic light scattering and analytical ultracentrifugation for the sizing of poly(butyl cyanoacrylate) nanoparticles.

V. Vogel, J. Kreuter, D. Schubert, 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Use of liposomes, viral capsids, and nanoparticles as DNA carriers

A. Zimmer, J. Kreuter, W. Bertling, 1991, Biotechnology and applied biochemistry.

Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles

J. Kreuter, A. Gulyaev, S. Gelperina, 1999, Pharmaceutical Research.

Delivery of Loperamide Across the Blood-Brain Barrier with Polysorbate 80-Coated Polybutylcyanoacrylate Nanoparticles

D. A. Kharkevich, J. Kreuter, K. Langer, 1997, Pharmaceutical Research.

Nanoparticles--a historical perspective.

J. Kreuter, 2007, International journal of pharmaceutics.

Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones.

D. Begley, H. von Briesen, J. Kreuter, 2009, Journal of controlled release : official journal of the Controlled Release Society.

Direct Evidence That Polysorbate-80-Coated Poly(Butylcyanoacrylate) Nanoparticles Deliver Drugs to the CNS via Specific Mechanisms Requiring Prior Binding of Drug to the Nanoparticles

D. Begley, B. Engelhardt, H. von Briesen, 2003, Pharmaceutical Research.

Antiparkinsonian effect of nerve growth factor adsorbed on polybutylcyanoacrylate nanoparticles coated with polysorbate-80

S. Seredenin, J. Kreuter, R. Alyautdin, 2008, Bulletin of Experimental Biology and Medicine.

Brain Targeting Of Nerve Growth Factor Using Poly(Butylcyanoacrylate) Nanoparticles

D. Begley, S. Trofimov, J. Kreuter, 2004 .

Preparation of biodegradable cyclosporine nanoparticles by high-pressure emulsification-solvent evaporation process.

S. Gupta, J. Kreuter, J. Jaiswal, 2004, Journal of controlled release : official journal of the Controlled Release Society.

Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB).

J. Kreuter, Jörg Kreuter, Karsten Ulbrich, 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Nanoparticulate systems for brain delivery of drugs.

J. Kreuter, Jörg Kreuter, 2001 .

Nanoparticulate systems for brain delivery of drugs.

J. Kreuter, J Kreuter, 2001, Advanced drug delivery reviews.

Apolipoprotein-mediated Transport of Nanoparticle-bound Drugs Across the Blood-Brain Barrier

Peter Ramge, Renad Alyautdin, J. Kreuter, 2002, Journal of drug targeting.

Uptake Mechanism of ApoE-Modified Nanoparticles on Brain Capillary Endothelial Cells as a Blood-Brain Barrier Model

H. von Briesen, J. Kreuter, F. Worek, 2012, PloS one.

Contrast Enhancement of the Brain by Folate-Conjugated Gadolinium–Diethylenetriaminepentaacetic Acid–Human Serum Albumin Nanoparticles by Magnetic Resonance Imaging

H. Ackermann, R. Hammerstingl, S. Zeuzem, 2012, Molecular imaging.

Antisense delivery using protamine-oligonucleotide particles.

A. Zimmer, M. Junghans, J. Kreuter, 2000, Nucleic acids research.

Phosphodiester and phosphorothioate oligonucleotide condensation and preparation of antisense nanoparticles.

A. Zimmer, M. Junghans, J. Kreuter, 2001, Biochimica et biophysica acta.

Delivery of doxorubicin-loaded PLGA nanoparticles into U87 human glioblastoma cells.

M. Gorshkova, J. Kreuter, V. Baklaushev, 2017, International journal of pharmaceutics.

Transport of Drugs Across the Blood-Brain Barrier by Nanoparticles

J. Kreuter, 2002 .

Brain targeting with surface-modified poly(D,L-lactic-co-glycolic acid) nanoparticles delivered via carotid artery administration.

Y. Kawashima, J. Kreuter, K. Tahara, 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

New adjuvants on a polymethylmethacrylate base

J. Kreuter, P. Speiser, J Kreuter, 1976, Infection and immunity.

The use of new polymethylmethacrylate adjuvants for split influenza vaccines.

J. Kreuter, P. Speiser, R. Mauler, 1976, Experimental cell biology.

Distribution and elimination of poly(methyl-2-14C-methacrylate) nanoparticle radioactivity after injection in rats and mice.

J. Kreuter, U. Täuber, V. Illi, 1979, Journal of pharmaceutical sciences.

Ocular drug delivery of progesterone using nanoparticles.

R. W. Wood, R W Wood, J. Kreuter, 1986, Journal of microencapsulation.

Large-scale production problems and manufacturing of nanoparticles

J. Kreuter, 1990 .

HI 6 human serum albumin nanoparticles--development and transport over an in vitro blood-brain barrier model.

H. von Briesen, J. Kreuter, F. Worek, 2011, Toxicology letters.

Transport of drugs across the blood-brain barrier by nanoparticles.

Svetlana Gelperina, J. Kreuter, S. Gelperina, 2012, Journal of controlled release : official journal of the Controlled Release Society.

Functionalized (poly(ɛ-caprolactone))₂-poly(ethylene glycol) nanoparticles with grafting nicotinic acid as drug carriers.

J. Kreuter, J. Suksiriworapong, Kittisak Sripha, 2012, International journal of pharmaceutics.

Potential of surfactant‐coated nanoparticles to improve brain delivery of arylsulfatase A

J. Kreuter, V. Gieselmann, S. Gelperina, 2017, Journal of controlled release : official journal of the Controlled Release Society.

Distribution and elimination of coated polymethyl [2-14C]methacrylate nanoparticles after intravenous injection in rats.

B. Manthey, J. Kreuter, P. Speiser, 1984, Journal of pharmaceutical sciences.

Correlation of the surface hydrophobicity of 14C-poly(methyl methacrylate) nanoparticles to their body distribution

R. Müller, J. Kreuter, S. Tröster, 1992 .

Tumour cell delivery of antisense oligonuclceotides by human serum albumin nanoparticles.

K. Strebhardt, J. Kreuter, K. Langer, 2004, Journal of controlled release : official journal of the Controlled Release Society.

Targeting by cmHsp70.1-antibody coated and survivin miRNA plasmid loaded nanoparticles to radiosensitize glioblastoma cells.

S. Hehlgans, C. Rödel, F. Rödel, 2013, Journal of controlled release : official journal of the Controlled Release Society.

Evaluation of aminoalkylmethacrylate nanoparticles as colloidal drug carrier systems. Part II: characterization of antisense oligonucleotides loaded copolymer nanoparticles.

A. Zimmer, C. Noe, J. Kreuter, 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

TARGETING VERSUS PROLONGED CIRCULATION

J. Kreuter, J. W. Goethe-Universitat, 1998 .

Recent Advances in Nanoparticles and Nanospheres

J. Kreuter, 1998 .

Coating of Nanoparticles with Surfactants: Targeting versus Prolonged Circulation

J. Kreuter, 1998 .

Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain.

J. Kreuter, 2004, Journal of nanoscience and nanotechnology.

Hydroxyurea-Loaded Albumin Nanoparticles: Preparation, Characterization, and In Vitro Studies

J. Kreuter, Y. Tazhbayev, Olzhas Mukashev, 2019, Pharmaceutics.

Freeze-drying of HI-6-loaded recombinant human serum albumin nanoparticles for improved storage stability.

H. von Briesen, J. Kreuter, F. Worek, 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Biodegradable human serum albumin nanoparticles as contrast agents for the detection of hepatocellular carcinoma by magnetic resonance imaging.

S. Zeuzem, T. Vogl, J. Kreuter, 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Human Serum Albumin-Based Nanoparticle-Mediated In Vitro Gene Delivery

M. Ruonala, J. Kreuter, M. Dadparvar, 2014, PloS one.

Adsorption of obidoxime onto human serum albumin nanoparticles: Drug loading, particle size and drug release

H. von Briesen, J. Kreuter, F. Worek, 2010, Journal of microencapsulation.

Enhanced drug targeting by attachment of an anti alphav integrin antibody to doxorubicin loaded human serum albumin nanoparticles.

I. Riemann, M. Michaelis, J. Cinatl, 2010, Biomaterials.

Incorporation of obidoxime into human serum albumin nanoparticles: optimisation of preparation parameters for the development of a stable formulation

J. Kreuter, F. Worek, Jürgen Kufleitner, 2010, Journal of microencapsulation.

Oligonucleotide-protamine-albumin nanoparticles: preparation, physical properties, and intracellular distribution.

A. Zimmer, U. Schubert, V. Vogel, 2005, Journal of controlled release : official journal of the Controlled Release Society.

Physicochemical characterization of protamine-phosphorothioate nanoparticles

A. Zimmer, V. Vogel, D. Schubert, 2004, Journal of microencapsulation.

Glycerol-l-lactide coating polymer leads to delay in bone ingrowth in hydroxyapatite implants.

O. Kilian, V. Alt, R. Schnettler, 2005, Journal of controlled release : official journal of the Controlled Release Society.

Effect of glycerol-L-lactide coating polymer on bone ingrowth of bFGF-coated hydroxyapatite implants.

V. Alt, R. Schnettler, J. Kreuter, 2004, Journal of controlled release : official journal of the Controlled Release Society.

Nanoparticles and microparticles for drug and vaccine delivery.

J. Kreuter, 1996, Journal of anatomy.

Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytes.

H. von Briesen, J. Kreuter, K. Langer, 2005, Biomaterials.

Degradation of microvascular brain endothelial cell beta-catenin after co-culture with activated neutrophils from patients undergoing cardiac surgery with prolonged cardiopulmonary bypass.

R. Blaheta, A. Moritz, G. Wimmer-Greinecker, 2005, Biochemical and biophysical research communications.

Evaluation of aminoalkylmethacrylate nanoparticles as colloidal drug carrier systems. Part I: Synthesis of monomers, dependence of the physical properties on the polymerization methods.

A. Zimmer, C. Noe, J. Kreuter, 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Distribution and elimination of poly(methyl methacrylate) nanoparticles after subcutaneous administration to rats.

J. Kreuter, M. Nefzger, E. Liehl, 1983, Journal of pharmaceutical sciences.

Phagocytosis and degradation of human serum albumin microspheres and nanoparticles in human macrophages.

H. von Briesen, A. Steffan, J. Kreuter, 1994, Journal of microencapsulation.

Distribution and elimination of polymethyl methacrylate nanoparticles after peroral administration to rats.

J. Kreuter, M. Nefzger, E. Liehl, 1984, Journal of pharmaceutical sciences.

Interaction of serum components with poly(methylmethacrylate) nanoparticles and the resulting body distribution after intravenous injection in rats.

G. Borchard, J. Kreuter, 1993, Journal of drug targeting.

[10] Poly(alkyl acrylate) nanoparticles

J. Kreuter, 1985 .

Effect of nanoparticles on transdermal drug delivery.

J. Kreuter, M. J. Cappel, 1991, Journal of microencapsulation.

Inhibition of HIV in vitro by antiviral drug-targeting using nanoparticles.

H. von Briesen, A. Steffan, J. Kreuter, 1994, Research in virology.

A solid colloidal drug delivery system for the eye: encapsulation of pilocarpin in nanoparticles.

J. Kreuter, P. Speiser, T. Harmia, 1986, Journal of microencapsulation.

Comparative study on the cytostatic effects and the tissue distribution of 5-fluorouracil in a free form and bound to polybutylcyanoacrylate nanoparticles in sarcoma 180-bearing mice.

J. Kreuter, H. Hartmann, 1983, Oncology.

Toxicity and association of polycyanoacrylate nanoparticles with hepatocytes.

J. Kreuter, C. Wilson, J. Fry, 1984, Journal of microencapsulation.

High antibody titres in mice with polymethylmethacrylate nanoparticles as adjuvant for HIV vaccines

J. Löwer, J. Kreuter, F. Stieneker, 1991, AIDS.

Hydrocortisone delivery to healthy and inflamed eyes using a micellar polysorbate 80 solution or albumin nanoparticles

J. Kreuter, P. Maincent, P. Thouvenot, 1994 .

Intracellular drug delivery using polysorbate 80-modified poly(D,L-lactide-co-glycolide) nanospheres to glioblastoma cells

Y. Kawashima, J. Kreuter, K. Tahara, 2011, Journal of microencapsulation.

Interaction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cells.

M. Michaelis, J. Cinatl, J. Kreuter, 2011, International journal of pharmaceutics.

Physico-chemical and toxicological characterization of iron-containing albumin nanoparticles as platforms for medical imaging.

P. Milani, F. Hübner, E. Scanziani, 2014, Journal of controlled release : official journal of the Controlled Release Society.

Doxorubicin-loaded PLGA nanoparticles for the chemotherapy of glioblastomas: Towards the pharmaceutical development.

V. Chekhonin, M. Gorshkova, J. Kreuter, 2019, International journal of pharmaceutics.

Peroral administration of nanoparticles

J. Kreuter, 1991 .

Studies on the transport pathway of PBCA nanoparticles in ocular tissues.

A. Zimmer, J. Robinson, J. Kreuter, 1991, Journal of microencapsulation.

Ocular disposition of poly-hexyl-2-cyano[3-14C]acrylate nanoparticles in the albino rabbit

R. W. Wood, J. Robinson, J. Kreuter, 1985 .

Evaluation of pilocarpine-loaded albumin particles as controlled drug delivery systems for the eye. II. Co-administration with bioadhesive and viscous polymers

J. Kreuter, M. F. Saettone, A. Zimmer, 1995 .

The Role of Serum Complement on the Organ Distribution of Intravenously Administered Poly (methyl methacrylate) Nanoparticles: Effects of Pre-Coating with Plasma and with Serum Complement

G. Borchard, J. Kreuter, 1996, Pharmaceutical Research.

Cationic polyhexylcyanoacrylate nanoparticles as carriers for antisense oligonucleotides.

A. Zimmer, C. Noe, J. Kreuter, 1997, Antisense & nucleic acid drug development.

Enhanced transport of nanoparticle associated drugs through natural and artificial membranes--a general phenomenon?

J. Kreuter, B. Müller, Joerg Kreuter, 1999, International journal of pharmaceutics.

Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma model

J. Kreuter, S. Gelperina, A. Khalansky, 2006, Journal of microencapsulation.

Phagocytosis of Nanoparticles by Human Immunodeficiency Virus (HlV)-Infected Macrophages: A Possibility for Antiviral Drug Targeting

R. Andreesen, H. von Briesen, A. Steffan, 1992, Pharmaceutical Research.

Microparticles derived from marine sponge collagen (SCMPs): preparation, characterization and suitability for dermal delivery of all-trans retinol.

J. Kreuter, W. Müller, W. Schatton, 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Mechanism of polymeric nanoparticle-based drug transport across the blood-brain barrier (BBB)

J. Kreuter, 2013, Journal of microencapsulation.

Detection of hepatocellular carcinoma in transgenic mice by Gd-DTPA- and rhodamine 123-conjugated human serum albumin nanoparticles in T1 magnetic resonance imaging.

F. Hübner, S. Zeuzem, T. Vogl, 2015, Journal of controlled release : official journal of the Controlled Release Society.

Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters.

J. Kreuter, S. Gelperina, O. Maksimenko, 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Intradermal air pouch leukocytosis as an in vivo test for nanoparticles

S. Michaeli, G. Opdenakker, I. Loinaz, 2013, International journal of nanomedicine.

Preparation and characterization of marine sponge collagen nanoparticles and employment for the transdermal delivery of 17β-estradiol-hemihydrate

Martin Nicklas, J. Kreuter, T. Hanke, 2009, Drug development and industrial pharmacy.

In vitro evaluation of biocompatibility of different wound dressing materials

B. Nies, J. Kreuter, A. Liebendörfer, 1995 .

Nanoencapsulation of antitumor and antituberculosis drug preparations with biocompatible polymers

J. Kreuter, A. Herk, Y. Tazhbayev, 2014 .

Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain.

J. Kreuter, K. Langer, S. Gelperina, 2007, Journal of controlled release : official journal of the Controlled Release Society.

Biodistribution of polysorbate 80-coated doxorubicin-loaded [14C]-poly(butyl cyanoacrylate) nanoparticles after intravenous administration to glioblastoma-bearing rats

D. Begley, J. Kreuter, S. Gelperina, 2006, Journal of drug targeting.

Transdermal delivery of the tetrapeptide hisetal (melanotropin (6–9)) and amino acids: their contribution to the elucidation of the existence of an ‘aqueous pore’ pathway

J. Kreuter, U. Rohr, A. Ruland, 1994 .

Production of nanoparticles: polymerization termination and molecular weights during radical-induced emulsifier-free emulsion polymerization (heterogeneous polymerization)

J. Kreuter, C. Marburger, 1998 .

Radiation sterilization of medicinal formulations of doxorubicin bound to poly(butylcyanoacrylate) nanoparticles

J. Kreuter, P. Sveshnikov, O. Maksimenko, 2008, Pharmaceutical Chemistry Journal.

Characterisation and stability studies of a hydrophilic decapeptide in different adjuvant drug delivery systems: a comparative study of PLGA nanoparticles versus chitosan-dextran sulphate microparticles versus DOTAP-liposomes.

J. Kreuter, A. Wieber, T. Selzer, 2011, International journal of pharmaceutics.

Cytotoxicity of aphidicolin and its derivatives against neuroblastoma cells in vitro: synergism with doxorubicin and vincristine

M. Michaelis, J. Cinatl, J. Cinatl, 2000, Anti-cancer drugs.

Historical Perspectives Nanoparticles — a historical perspective

J. Kreuter, 2010 .

Lymphatic Targeting of Polymeric Nanoparticles After Intraperitoneal Administration in Rats

P. Couvreur, J. Kreuter, P. Maincent, 1992, Pharmaceutical Research.

Antibiotic-impregnated heart valve sewing rings for treatment and prophylaxis of bacterial endocarditis

B. Nies, J. Kreuter, R. Wenz, 1996, Antimicrobial agents and chemotherapy.

Influence of Surface-Modifying Surfactants on the Pharmacokinetic Behavior of 14C-Poly (Methylmethacrylate) Nanoparticles in Experimental Tumor Models

I. Fichtner, R. Reszka, J. Kreuter, 2001, Pharmaceutical Research.

Toxicological studies of doxorubicin bound to polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles in healthy rats and rats with intracranial glioblastoma.

F. Zanella, B. Turowski, J. Kreuter, 2002, Toxicology letters.

Enhanced antisense efficacy of oligonucleotides adsorbed to monomethylaminoethylmethacrylate methylmethacrylate copolymer nanoparticles.

A. Zimmer, C. Noe, M. Junghans, 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Polysorbate‐80 coating enhances uptake of polybutylcyanoacrylate (PBCA)‐nanoparticles by human and bovine primary brain capillary endothelial cells

D. Begley, R. Unger, H. von Briesen, 2000, The European journal of neuroscience.

Uptake of surfactant-coated poly(methyl methacrylate)-nanoparticles by bovine brain microvessel endothelial cell monolayers

K. Audus, G. Borchard, J. Kreuter, 1994 .

Delivery of liposome membrane-associated sterols through silastic membranes.

N. Weiner, J. Kreuter, W. Higuchi, 1981, Biochimica et biophysica acta.

Influence of Chronobiology on the Nanoparticle-Mediated Drug Uptake into the Brain

J. Kreuter, 2015, Pharmaceutics.

Adsorption of monoclonal antibodies to polyhexylcyanoacrylate nanoparticles and subsequent immunospecific binding to tumour cells in vitro

R. W. Baldwin, S. Davis, J. Kreuter, 1983 .

Distribution of polyhexyl cyanoacrylate nanoparticles in nude mice bearing human osteosarcoma.

J. Kreuter, R. Arshady, P. Speiser, 1986, Journal of pharmaceutical sciences.

Antiviral and immunomodulatory activity of the metal chelator ethylenediaminedisuccinic acid against cytomegalovirus in vitro and in vivo.

E. De Clercq, H. Doerr, R. Blaheta, 2002, Antiviral research.

Marine sponge collagen: isolation, characterization and effects on the skin parameters surface-pH, moisture and sebum.

Josef Kellermann, Werner E G Müller, J. Kellermann, 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Microspheres and nanoparticles used in ocular delivery systems

Andreas Zimmer, A. Zimmer, J. Kreuter, 1995 .

Towards hybrid biocompatible magnetic rHuman serum albumin-based nanoparticles: use of ultra-small (CeLn)3/4+ cation-doped maghemite nanoparticles as functional shell

L. Israel, J. Lellouche, J. Kreuter, 2015, Nanotechnology.

Chemotherapy of glioblastoma in rats using doxorubicin‐loaded nanoparticles

K. Geiger, S. Steiniger, J. Kreuter, 2004, International journal of cancer.

Effect of nonionic surfactants on transdermal drug delivery: I. Polysorbates

J. Kreuter, M. J. Cappel, 1991 .

Improved delivery of methoxsalen.

J. Kreuter, T. Higuchi, 1979, Journal of pharmaceutical sciences.

Use of isothermal heat conduction microcalorimetry, X-ray diffraction, and optical microscopy for characterisation of crystals grown in steroid combination-containing transdermal drug delivery systems.

M. Horstmann, J. Kreuter, T. Selzer, 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Determination of the physical state of norethindrone acetate containing transdermal drug delivery systems by isothermal microcalorimetry, X-ray diffraction, and optical microscopy.

J. Kreuter, T. Selzer, L. Fink, 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines.

R. Breitling, B. Mayer, H. Doerr, 2010, Biochemical pharmacology.

Incorporation of basic fibroblast growth factor into methylpyrrolidinone chitosan fleeces and determination of the in vitro release characteristics.

B. Nies, J. Kreuter, A. Liebendörfer, 1994, Biomaterials.

Nanoparticle-based dmg delivery systems

J. Kreuter, 1991 .

Carrier-Mediated Antiviral Therapy

M. Kende, J. Kreuter, W. Lange, 1988 .

Ocular therapeutics and drug delivery

J. Kreuter, 1997 .

Radiation sterilisation of doxorubicin bound to poly(butyl cyanoacrylate) nanoparticles.

J. Kreuter, S. Gelperina, O. Maksimenko, 2008, International journal of pharmaceutics.

Evaluation of pilocarpine-loaded albumin particles as drug delivery systems for controlled delivery in the eye. I: In vitro and in vivo characterisation

J. Kreuter, A. Zimmer, H. Zerbe, 1994 .

Effect of liposomes on percutaneous penetration of lipophilic materials

J. Kreuter, C. Michel, E. Mentrup, 1992 .

Particulates (Nanoparticles and Microparticles)

J. Kreuter, 1993 .

Xenograft Model for Identifying Chemotherapeutic Agents against Papillomaviruses

J. Kreuter, A. Pawellek, H. Rübsamen-Waigmann, 2001, Antimicrobial Agents and Chemotherapy.

Effect of nonionic surfactants on transdermal drug delivery: II. Poloxamer and poloxamine surfactants

J. Kreuter, M. J. Cappel, 1991 .

DNA from bovine papillomavirus type 2 induces warts in a xenograft model.

J. Kreuter, A. Pawellek, M. Rosenbruch, 2002, Virus research.

Investigation of polymer and nanoparticle properties with nicotinic acid and p-aminobenzoic acid grafted on poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) via click chemistry.

J. Kreuter, J. Suksiriworapong, V. Junyaprasert, 2011, Bioconjugate chemistry.

Ethylcellulose: a new type of emulsion stabilizer.

R. Daniels, J. Kreuter, E. Melzer, 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Body distribution of polysorbate‐80 and doxorubicin-loaded [14C]poly(butyl cyanoacrylate) nanoparticles after i.v. administration in rats

J. Kreuter, Hiromitsu Yamamoto, A. Ambruosi, 2005, Journal of drug targeting.

Optimization of pilocarpine loading onto nanoparticles by sorption procedures

J. Kreuter, P. Speiser, T. Harmia, 1986 .

Human serum albumin-polyethylenimine nanoparticles for gene delivery.

H. von Briesen, J. Kreuter, K. Langer, 2003, Journal of controlled release : official journal of the Controlled Release Society.

Crystallisation of estradiol containing TDDS determined by isothermal microcalorimetry, X-ray diffraction, and optical microscopy.

J. Kreuter, T. Selzer, L. Fink, 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Specific targeting of HER2 overexpressing breast cancer cells with doxorubicin-loaded trastuzumab-modified human serum albumin nanoparticles.

Sylvia Wagner, Hagen von Briesen, H. von Briesen, 2008, Bioconjugate chemistry.

Efficiency of nanoparticles as a carrier system for antiviral agents in human immunodeficiency virus-infected human monocytes/macrophages in vitro

H. von Briesen, J. Kreuter, I. Duncan, 1996, Antimicrobial agents and chemotherapy.

Human serum albumin nanoparticles modified with apolipoprotein A-I cross the blood-brain barrier and enter the rodent brain

D. Begley, J. Kreuter, Larisa Mihoreanu, 2010, Journal of drug targeting.

The Blood-brain Barrier and Drug Delivery to the CNS

David J. Begley, D. Begley, J. Kreuter, 2000 .

Intracellular tracking of protamine/antisense oligonucleotide nanoparticles and their inhibitory effect on HIV-1 transactivation.

Hagen von Briesen, Andreas Zimmer, Dirk Lochmann, 2004, Journal of controlled release : official journal of the Controlled Release Society.

Coupling of the antitumoral enzyme bovine seminal ribonuclease to polyethylene glycol chains increases its systemic efficacy in mice

M. Michaelis, J. Cinatl, J. Matoušek, 2002, Anti-cancer drugs.

Bovine seminal ribonuclease attached to nanoparticles made of polylactic acid kills leukemia and lymphoma cell lines in vitro

M. Michaelis, J. Cinatl, J. Vogel, 2000, Anti-cancer drugs.

Body distribution of free, liposomal and nanoparticle-associated mitoxantrone in B16-melanoma-bearing mice.

I. Fichtner, J. Kreuter, M. Hentschel, 1997, The Journal of pharmacology and experimental therapeutics.

Physico-chemical characterisation of cationic DOTAP liposomes as drug delivery system for a hydrophilic decapeptide before and after freeze-drying.

J. Kreuter, A. Wieber, T. Selzer, 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Drug delivery to the central nervous system by polymeric nanoparticles: what do we know?

J. Kreuter, Jörg Kreuter, 2014, Advanced drug delivery reviews.

In vitro studies of poly(methyl methacrylate) adjuvants.

J. Kreuter, P. Speiser, J Kreuter, 1976, Journal of pharmaceutical sciences.

Dihydroxythiophenes Are Novel Potent Inhibitors of Human Immunodeficiency Virus Integrase with a Diketo Acid-Like Pharmacophore

A. Göller, J. Kreuter, A. Birkmann, 2006, Journal of Virology.

Mode of action of immunological adjuvants: some physicochemical factors influencing the effectivity of polyacrylic adjuvants

J. Kreuter, I. Haenzel, 1978, Infection and immunity.

Protection induced by inactivated influenza virus vaccines with polymethylmethacrylate adjuvants

J. Kreuter, E. Liehl, 1978, Medical Microbiology and Immunology.

Anticancer effects of the nitric oxide-modified saquinavir derivative saquinavir-NO against multidrug-resistant cancer cells.

J. Otte, H. Doerr, F. Nicoletti, 2010, Neoplasia.

Influence of the formulation on the tolerance profile of nanoparticle-bound doxorubicin in healthy rats: focus on cardio- and testicular toxicity.

J. Kreuter, K. Langer, S. Gelperina, 2007, International journal of pharmaceutics.

Toxicological study of doxorubicin‐loaded PLGA nanoparticles for the treatment of glioblastoma

J. Kreuter, S. Gelperina, V. Balabanyan, 2019, International journal of pharmaceutics.

Nanoparticulate Transport of Oximes over an In Vitro Blood-Brain Barrier Model

H. von Briesen, J. Kreuter, F. Worek, 2010, PloS one.

Functional Protein Delivery into Neurons Using Polymeric Nanoparticles*

J. Kreuter, H. Hattori, J. George, 2009, Journal of Biological Chemistry.

Possibilities of using nanoparticles as carriers for drugs and vaccines.

J. Kreuter, J Kreuter, 1988, Journal of microencapsulation.

Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants.

R. Müller, J. Kreuter, A. Bootz, 2007, Journal of controlled release : official journal of the Controlled Release Society.

Molecular weights of poly(butyl cyanoacrylate) nanoparticles determined by mass spectrometry and size exclusion chromatography.

Friedhelm Gores, Thomas Russ, Michael Karas, 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Intravenous tolerance of a nanoparticle-based formulation of doxorubicin in healthy rats.

J. Kreuter, S. Gelperina, J Kreuter, 2008, Toxicology letters.

Cytotoxicity of doxorubicin bound to poly(butyl cyanoacrylate) nanoparticles in rat glioma cell lines using different assays

H. von Briesen, J. Kreuter, S. Gelperina, 2006, Journal of drug targeting.

Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)

J. Kreuter, R. Alyautdin, Jörg Kreuter, 1995, Brain Research.

Influence of enzymes on the stability of polybutylcyanoacrylate nanoparticles

J. Robinson, J. Kreuter, D. Scherer, 1994 .

Influence of hydrophobicity on the adjuvant effect of particulate polymeric adjuvants.

J. Kreuter, M. Soliva, P. Speiser, 1988, Vaccine.

Influence of the particle size on the adjuvant effect of particulate polymeric adjuvants.

J. Kreuter, M. Soliva, P. Speiser, 1986, Vaccine.

Long-term studies of microencapsulated and adsorbed influenza vaccine nanoparticles.

J. Kreuter, E. Liehl, J Kreuter, 1981, Journal of pharmaceutical sciences.

Using Nanoparticles to Target Drugs to the Central Nervous System

J. Kreuter, R. Alyautdin, 2000 .

Use of Nanoparticles for Cerebral Cancer

J. Kreuter, S. Gelperina, 2008 .

Use of nanoparticles for cerebral cancer.

J. Kreuter, S. Gelperina, 2008, Tumori.

Brain-derived neurotrophic factor delivered to the brain using poly (lactide-co-glycolide) nanoparticles improves neurological and cognitive outcome in mice with traumatic brain injury

Tin Wui Wong, Renad Alyautdin, J. Kreuter, 2016, Drug delivery.

Application of nanoparticles for the delivery of drugs to the brain

J. Kreuter, Jörg Kreuter, 2005 .

Enhancement of the myotic response of rabbits with pilocarpine-loaded polybutylcyanoacrylate nanoparticles

R. Gurny, J. Kreuter, P. Speiser, 1986 .

Polybutylcyanoacrylate nanoparticles for the delivery of [75Se]norcholestenol

Clive G. Wilson, J. Kreuter, S. Mills, 1983 .

Physicochemical characterisation of cationic polybutylcyanoacrylate-nanoparticles by fluorescence correlation spectroscopy.

A. Zimmer, M. Karas, J. Weyermann, 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Highly Specific HER2-mediated Cellular Uptake of Antibody-modified Nanoparticles in Tumour Cells

K. Strebhardt, J. Kreuter, K. Langer, 2004, Journal of drug targeting.

Poly(Methyl Methacrylate) Nanoparticles As Vaccine Adjuvants

J. Kreuter, 2000 .

Development of nanoparticle-bound arylsulfatase B for enzyme replacement therapy of mucopolysaccharidosis VI.

J. Kreuter, S. Gelperina, A. Mühlstein, 2013, Die Pharmazie.

Nanoparticles as carriers for drug delivery of macromolecules across the blood-brain barrier

J. Duskey, G. Tosi, J. Kreuter, 2019, Expert opinion on drug delivery.

The use of 60Co-γ-irradiation for the production of vaccines

J. Kreuter, H. Zehnder, 1978 .

Drug targeting with nanoparticles

J. Kreuter, 1994, European Journal of Drug Metabolism and Pharmacokinetics.

Drug and vehicle deposition from topical applications: use of in vitro mass balance technique with minoxidil solutions.

N. Weiner, G. Flynn, J. Ferry, 1992, Journal of pharmaceutical sciences.

Influence of Chitosan Microspheres on the Transport of Prednisolone Sodium Phosphate Across HT-29 Cell Monolayers

W. Domschke, J. Kreuter, A. Berthold, 2004, Pharmaceutical Research.

The effects of polyalkylcyanoacrylate nanoparticles on human normal and malignant mesenchymal cells in vitro

J. Kreuter, P. Speiser, P. Groscurth, 1987 .

Enteric coating derived from marine sponge collagen

Martin Nicklas, J. Kreuter, T. Hanke, 2009, Drug development and industrial pharmacy.

Pharmacokinetic and Pharmacodynamic Aspects of an Ophthalmic Pilocarpine Nanoparticle-Delivery-System

A. Zimmer, J. Kreuter, E. Mutschler, 1994, Pharmaceutical Research.

Targeting the insulin receptor: nanoparticles for drug delivery across the blood–brain barrier (BBB)

Thomas Knobloch, J. Kreuter, T. Knobloch, 2011, Journal of drug targeting.

Histone deacetylase inhibitors suppress natural killer cell cytolytic activity

Jindrich Cinatl, Martin Michaelis, H. Doerr, 2007, FEBS letters.

Fluorescently Labeled PLGA Nanoparticles for Visualization In Vitro and In Vivo: The Importance of Dye Properties

Yaroslav V. Solovev, Y. Porozov, P. Henrich-Noack, 2021, Pharmaceutics.

Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytes.

Hagen von Briesen, H. von Briesen, J. Kreuter, 2005, Biomaterials.

Interaction of rubber closures with powders for parenteral administration.

J. Kreuter, R. W. Jähnke, G. Ross, 1990, Journal of parenteral science and technology : a publication of the Parenteral Drug Association.

Use of isothermal heat conduction microcalorimetry to evaluate stability and excipient compatibility of a solid drug

J. Kreuter, T. Selzer, M. Radau, 1998 .

Pharmacological activity of DTPA linked to protein-based drug carrier systems.

H. Doerr, M. Michaelis, J. Cinatl, 2004, Biochemical and biophysical research communications.

Efficient Chemotherapy of Rat Glioblastoma Using Doxorubicin-Loaded PLGA Nanoparticles with Different Stabilizers

M. Glatzel, J. Kreuter, S. Gelperina, 2011, PloS one.

Adsorption of plasma proteins on uncoated PLGA nanoparticles.

Svetlana Gelperina, Michael Karas, Tabiwang N. Arrey, 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Arylsulfatase A bound to poly(butyl cyanoacrylate) nanoparticles for enzyme replacement therapy--physicochemical evaluation.

J. Kreuter, S. Gelperina, O. Maksimenko, 2014, Die Pharmazie.

Nanoparticle‐based delivery of carbamazepine: A promising approach for the treatment of refractory epilepsy

V. Chekhonin, J. Kreuter, V. Baklaushev, 2018, International journal of pharmaceutics.

In vitro Antiviral Activity of Aphidicolin and its Derivates

H. Doerr, M. Michaelis, J. Cinatl, 2002, Arzneimittelforschung.

Influence of HIV-infection on the phagocytic activity of monocytes/macrophages and granulocytes.

H. von Briesen, J. Kreuter, H. Rübsamen-Waigmann, 1994, Clinical and diagnostic virology.

Targeted diagnostic magnetic nanoparticles for medical imaging of pancreatic cancer.

P Knoll, S Mirzaei, C Weis, 2015, Journal of controlled release : official journal of the Controlled Release Society.

Survivin-miRNA-loaded nanoparticles as auxiliary tools for radiation therapy: preparation, characterisation, drug release, cytotoxicity and therapeutic effect on colorectal cancer cells

C. Rödel, F. Rödel, J. Kreuter, 2012, Journal of microencapsulation.

On the mechanism of termination in heterogeneous polymerization

J. Kreuter, Jörg Kreuter, 1982 .

Encapsulation of water-insoluble drugs in poly(butyl cyanoacrylate) nanoparticles.

V. Vogel, J. Kreuter, S. Gelperina, 2009, Journal of nanoscience and nanotechnology.

Treatment of glioblastoma with poly(isohexyl cyanoacrylate) nanoparticles.

M. Michaelis, J. Cinatl, M. Glatzel, 2011, International journal of pharmaceutics.

The potential of polymeric nanoparticles to increase the immunogenicity of the hapten clenbuterol

C. Elliott, J. Kreuter, D. Mackie, 1997 .

Nanoparticles as adjuvants for vaccines.

J. Kreuter, 1995, Pharmaceutical biotechnology.

Pharmacophore Virus Integrase with a Diketo Acid-Like Inhibitors of Human Immunodeficiency Dihydroxythiophenes Are Novel Potent

A. Göller, J. Kreuter, A. Birkmann, 2006 .

Nanoparticles as drug carriers in ophthalmology.

J. Kreuter, P. Speiser, P Speiser, 1987, Pharmaceutica acta Helvetiae.

Distribution of polyhexylcyanoacrylate nanoparticles in nude mice over extended times and after repeated injection.

J. Kreuter, P. Speiser, P. Groscurth, 1988, Journal of pharmaceutical sciences.

Neuroprotective Activity of a Nanoparticulate Formulation of the GlycineB Site Antagonist MRZ 2/576 in Transient Focal Ischaemia in Rats

W. Danysz, J. Kreuter, S. Schweizer, 2002, Arzneimittelforschung.

Oligonucleotide-protamine-albumin nanoparticles: Protamine sulfate causes drastic size reduction.

A. Zimmer, U. Schubert, V. Vogel, 2005, Journal of controlled release : official journal of the Controlled Release Society.

Sorption of 5-fluorouracil from aqueous solutions onto methyl methacrylate nanoparticles.

J. Kreuter, P. Speiser, Atilla A. Hincal, 1986, Journal of microencapsulation.

Molecular weights of polycyanoacrylate nanoparticles

J. Kreuter, M. A. el-Egakey, Verena Bentele, 1983 .

Molecular weights of poly(methyl methacrylate) nanoparticles

J. Kreuter, U. Berg, Verena Bentele, 1982 .

Nanoparticles – Colloidal Delivery Systems for Drugs and Vaccines

J. Kreuter, 2005 .

The influence of coatings with surfactants on the body distribution of nanoparticles after intravenous injection to rats

J. Kreuter, 1993 .

Nanoparticles as Potent Adjuvants for Vaccines

J. Kreuter, 1993 .

Improved peroral delivery of avarol with polybutylcyanoacrylate nanoparticles

J. Kreuter, W. Müller, W. Schatton, 1994 .

Efficient systemic therapy of rat glioblastoma by nanoparticle-bound doxorubicin is due to antiangiogenic effects.

M. Glatzel, J. Matschke, J. Kreuter, 2009, Clinical neuropathology.

Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles.

M. Michaelis, J. Cinatl, J. Kreuter, 2007, International journal of pharmaceutics.

Increased Numbers of Injections of Doxorubicin Bound to Nanoparticles Lead to Enhanced Efficacy Against Rat Glioblastoma 101/8

M. Glatzel, J. Kreuter, S. Gelperina, 2009 .

Macrophage targeting of azidothymidine: a promising strategy for AIDS therapy.

R. Löbenberg, J. Kreuter, J. Kreuter, 1996, AIDS research and human retroviruses.

Physicochemical characterization of polyacrylic nanoparticles

J. Kreuter, 1983 .

Gelatin nanoparticles by two step desolvation--a new preparation method, surface modifications and cell uptake.

J. Kreuter, K. Langer, J. Kreuter, 2000, Journal of microencapsulation.

JÖRG KREUTER , INSTITUTE OF PHARMACEUTICAL TECHNOLOGY Nanoparticles as Drug Carriers DRUG TARGETING OF DRUGS AND NUCLEIC ACIDS

J. Kreuter, 2009 .

Nanoparticulate Carriers for Drug Delivery to the Brain

J. Kreuter, 2006 .

Increase of the duration of the anticonvulsive activity of a novel NMDA receptor antagonist using poly(butylcyanoacrylate) nanoparticles as a parenteral controlled release system.

J. Kreuter, G. Quack, B. Lorenz, 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Preparation and characterization of marine sponge collagen nanoparticles and employment for the transdermal delivery of 17β-estradiol-hemihydrate

Martin Nicklas, J. Kreuter, T. Hanke, 2009, Drug development and industrial pharmacy.

Determination of Free Apolipoprotein(a) in Serum by Immunoassay and Its Significance for Risk Assessment in Patients with Coronary Artery Disease

H. Hahmann, W. Herrmann, J. Kreuter, 1999, Clinical chemistry and laboratory medicine.